| Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies YZ Jiang, D Ma, C Suo, J Shi, M Xue, X Hu, Y Xiao, KD Yu, YR Liu, Y Yu, ... Cancer cell 35 (3), 428-440. e5, 2019 | 738 | 2019 |
| Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer YR Liu, YZ Jiang, XE Xu, KD Yu, X Jin, X Hu, WJ Zuo, S Hao, J Wu, ... Breast Cancer Research 18, 1-10, 2016 | 233 | 2016 |
| Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study Y Gong, YR Liu, P Ji, X Hu, ZM Shao Scientific reports 7 (1), 45411, 2017 | 228 | 2017 |
| Transcriptome analysis of triple-negative breast cancer reveals an integrated mRNA-lncRNA signature with predictive and prognostic value YZ Jiang, YR Liu, XE Xu, X Jin, X Hu, KD Yu, ZM Shao Cancer research 76 (8), 2105-2114, 2016 | 186 | 2016 |
| Tinagl1 suppresses triple-negative breast cancer progression and metastasis by simultaneously inhibiting integrin/FAK and EGFR signaling M Shen, YZ Jiang, Y Wei, B Ell, X Sheng, M Esposito, J Kang, X Hang, ... Cancer cell 35 (1), 64-80. e7, 2019 | 168 | 2019 |
| Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients L Chen, L Yang, L Yao, XY Kuang, WJ Zuo, S Li, F Qiao, YR Liu, ZG Cao, ... Nature communications 9 (1), 1357, 2018 | 146 | 2018 |
| The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation X Jin, XE Xu, YZ Jiang, YR Liu, W Sun, YJ Guo, YX Ren, WJ Zuo, X Hu, ... Science advances 5 (3), eaat9820, 2019 | 101 | 2019 |
| Comprehensive transcriptome profiling reveals multigene signatures in triple-negative breast cancer YR Liu, YZ Jiang, XE Xu, X Hu, KD Yu, ZM Shao Clinical cancer research 22 (7), 1653-1662, 2016 | 87 | 2016 |
| PHF5A epigenetically inhibits apoptosis to promote breast cancer progression YZ Zheng, MZ Xue, HJ Shen, XG Li, D Ma, Y Gong, YR Liu, F Qiao, ... Cancer Research 78 (12), 3190-3206, 2018 | 71 | 2018 |
| Androgen receptor expression predicts different clinical outcomes for breast cancer patients stratified by hormone receptor status HS Jiang, XY Kuang, WL Sun, Y Xu, YZ Zheng, YR Liu, GT Lang, F Qiao, ... Oncotarget 7 (27), 41285, 2016 | 69 | 2016 |
| Stathmin and phospho-stathmin protein signature is associated with survival outcomes of breast cancer patients XY Kuang, L Chen, ZJ Zhang, YR Liu, YZ Zheng, H Ling, F Qiao, S Li, ... Oncotarget 6 (26), 22227, 2015 | 53 | 2015 |
| Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer D Ma, YZ Jiang, XY Liu, YR Liu, ZM Shao Breast cancer research and treatment 162, 39-48, 2017 | 52 | 2017 |
| Elevated miR-301a expression indicates a poor prognosis for breast cancer patients JZ Zheng, YN Huang, L Yao, YR Liu, S Liu, X Hu, ZB Liu, ZM Shao Scientific reports 8 (1), 2225, 2018 | 50 | 2018 |
| High expression of microRNA-454 is associated with poor prognosis in triple-negative breast cancer ZG Cao, JJ Li, L Yao, YN Huang, YR Liu, X Hu, CG Song, ZM Shao Oncotarget 7 (40), 64900, 2016 | 47 | 2016 |
| The phosphorylation-specific association of STMN1 with GRP78 promotes breast cancer metastasis XY Kuang, HS Jiang, K Li, YZ Zheng, YR Liu, F Qiao, S Li, X Hu, ZM Shao Cancer Letters 377 (1), 87-96, 2016 | 41 | 2016 |
| Protein C receptor is a therapeutic stem cell target in a distinct group of breast cancers D Wang, X Hu, C Liu, Y Jia, Y Bai, C Cai, J Wang, L Bai, R Yang, CD Lin, ... Cell research 29 (10), 832-845, 2019 | 37 | 2019 |
| Positive expression of miR-361-5p indicates better prognosis for breast cancer patients ZG Cao, YN Huang, L Yao, YR Liu, X Hu, YF Hou, ZM Shao Journal of thoracic disease 8 (7), 1772, 2016 | 36 | 2016 |
| Nomograms to estimate long-term overall survival and breast cancer-specific survival of patients with luminal breast cancer W Sun, YZ Jiang, YR Liu, D Ma, ZM Shao Oncotarget 7 (15), 20496, 2016 | 35 | 2016 |
| Different patterns in the prognostic value of age for breast cancer-specific mortality depending on hormone receptor status: a SEER population-based analysis YR Liu, YZ Jiang, KD Yu, ZM Shao Annals of surgical oncology 22, 1102-1110, 2015 | 32 | 2015 |
| Epidemiology and survival outcomes of mucinous adenocarcinomas: A SEER population-based study GD Xie, YR Liu, YZ Jiang, ZM Shao Scientific reports 8 (1), 6117, 2018 | 31 | 2018 |
